Jianyang Wang

1.5k total citations
90 papers, 807 citations indexed

About

Jianyang Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jianyang Wang has authored 90 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 23 papers in Surgery. Recurrent topics in Jianyang Wang's work include Lung Cancer Diagnosis and Treatment (26 papers), Lung Cancer Treatments and Mutations (23 papers) and Lung Cancer Research Studies (15 papers). Jianyang Wang is often cited by papers focused on Lung Cancer Diagnosis and Treatment (26 papers), Lung Cancer Treatments and Mutations (23 papers) and Lung Cancer Research Studies (15 papers). Jianyang Wang collaborates with scholars based in China, United States and Saudi Arabia. Jianyang Wang's co-authors include Paul T. Englund, Nan Bi, Robert E. Jensen, Gokben Yildirir, Ye‐Xiong Li, Lei Deng, Zhouguang Hui, Lühua Wang, Jing Jin and Zongmei Zhou and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jianyang Wang

74 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianyang Wang China	18	285	251	237	170	164	90	807
Kedar Deodhar India	17	132 0.5×	316 1.3×	240 1.0×	337 2.0×	113 0.7×	100	977
Peter Barry United Kingdom	18	255 0.9×	320 1.3×	242 1.0×	167 1.0×	349 2.1×	59	1.1k
Orla McArdle Ireland	13	141 0.5×	154 0.6×	82 0.3×	137 0.8×	150 0.9×	39	832
Wenhu Chen China	17	321 1.1×	201 0.8×	261 1.1×	248 1.5×	209 1.3×	66	1.3k
Jonas J. Heymann United States	15	289 1.0×	334 1.3×	171 0.7×	144 0.8×	170 1.0×	47	1.1k
Kathrin Scheckenbach Germany	25	143 0.5×	513 2.0×	464 2.0×	96 0.6×	221 1.3×	64	1.4k
Naoki Morimoto Japan	13	199 0.7×	113 0.5×	128 0.5×	141 0.8×	73 0.4×	61	707
Haruhiko Takeda Japan	22	213 0.7×	251 1.0×	175 0.7×	508 3.0×	209 1.3×	69	1.2k
Fernando A. Angarita Canada	17	172 0.6×	533 2.1×	254 1.1×	85 0.5×	267 1.6×	51	970
Ekkasit Tharavichitkul Thailand	15	180 0.6×	219 0.9×	146 0.6×	141 0.8×	91 0.6×	69	820

Countries citing papers authored by Jianyang Wang

Since Specialization

Citations

This map shows the geographic impact of Jianyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyang Wang more than expected).

Fields of papers citing papers by Jianyang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyang Wang. The network helps show where Jianyang Wang may publish in the future.

Co-authorship network of co-authors of Jianyang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianyang Wang. A scholar is included among the top collaborators of Jianyang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianyang Wang. Jianyang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jie, Zongmei Zhou, Nan Bi, et al.. (2025). A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort study. Therapeutic Advances in Medical Oncology. 17. 22808630–22808630.

Wu, Yuqi, Lei Deng, Jianyang Wang, et al.. (2025). Single-arm phase II study of consolidation serplulimab following hypofractionated radiotherapy with concurrent chemotherapy for patients with limited stage small-cell lung cancer: ASTRUM-LC01 study protocol. BMJ Open. 15(5). e085552–e085552.

Liu, Yunsong, Yu Men, Xu Yang, et al.. (2025). Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous-cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis. Radiation Oncology. 20(1). 38–38.

Luo, Shi‐Hong, et al.. (2024). Synergistic effects of Ω-3 polyunsaturated fatty acid supplementation and programmed cell death protein 1 blockade on tumor growth and immune modulation in a xenograft model of esophageal cancer. Clinical Nutrition ESPEN. 61. 308–315. 5 indexed citations

Wu, Yuqi, Canjun Li, Yin Yang, et al.. (2024). Predicting Disease Progression in Inoperable Localized NSCLC Patients Using ctDNA Machine Learning Model. Cancer Medicine. 13(20). e70316–e70316. 4 indexed citations

Wang, Yu, Wenqing Wang, Tao Zhang, et al.. (2024). Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy. SHILAP Revista de lepidopterología. 4(2). 177–187. 3 indexed citations

Wang, Jianyang, Fei Han, Yuchao Ma, et al.. (2023). Effect of Segmental Abutting Esophagus-Sparing Technique to Reduce Severe Esophagitis in Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Hypofractionated Thoracic Radiation and Chemotherapy. Cancers. 15(5). 1487–1487. 1 indexed citations

Tang, Wei, et al.. (2023). Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series. Frontiers in Oncology. 13. 1021253–1021253. 1 indexed citations

Yu, Nuo, Tao Zhang, Jianyang Wang, et al.. (2022). Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma. Clinical and Translational Medicine. 12(11). e1116–e1116. 25 indexed citations

10.

Zhang, Yubo, Shuang Han, Zhongxin Zhang, Jianyang Wang, & Hongbo Bi. (2022). CF-GAN: cross-domain feature fusion generative adversarial network for text-to-image synthesis. The Visual Computer. 21 indexed citations

11.

Wang, Jianyang, et al.. (2022). Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism. Frontiers in Cellular and Infection Microbiology. 12. 828605–828605. 5 indexed citations

12.

Yang, Yin, Jianyang Wang, Wenqing Wang, et al.. (2022). Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis. Frontiers in Oncology. 12. 1007862–1007862. 2 indexed citations

13.

Zhang, Jinyao, Yan Wang, Ziling Liu, et al.. (2021). Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases. Thoracic Cancer. 12(24). 3407–3415. 23 indexed citations

14.

Wang, Shulian, Ge Wen, Yu Tang, et al.. (2020). Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions. BMC Cancer. 20(1). 792–792. 12 indexed citations

15.

Gong, Mengchun, Shuang Wang, Jianyang Wang, et al.. (2019). Evaluation of Privacy Risks of Patients’ Data in China: Case Study. JMIR Medical Informatics. 8(2). e13046–e13046. 12 indexed citations

16.

Huang, Zhou, Yu Tang, Shulian Wang, et al.. (2019). Predicting the risk of non-sentinel lymph node metastasis in breast cancer patients with 1-2 positive sentinel lymph nodes. Zhonghua fangshe zhongliuxue zazhi. 28(2). 102–107. 1 indexed citations

17.

Kang, Jingjing, et al.. (2019). Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease Markers. 2019. 1–10. 6 indexed citations

18.

Wang, Jianyang, Yuan Tian, Yuan Tang, et al.. (2016). Effect of MRI-guided intensity-modulated radiotherapy with bone marrow protection on hematologic toxicity in patients with rectal cancer undergoing concurrent chemoradiotherapy. Zhonghua fangshe zhongliuxue zazhi. 25(3). 244–248. 1 indexed citations

19.

Wang, Jianyang, Yuan Tian, Yuan Tang, et al.. (2016). A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy. OncoTargets and Therapy. 9. 2701–2701. 8 indexed citations

20.

Liu, Beiyu, Jianyang Wang, Gokben Yildirir, & Paul T. Englund. (2009). TbPIF5 Is a Trypanosoma brucei Mitochondrial DNA Helicase Involved in Processing of Minicircle Okazaki Fragments. PLoS Pathogens. 5(9). e1000589–e1000589. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact